As revealed in our previous studies, MeCP2 facilitates gastric cancer cell proliferation and inhibits cell apoptosis through suppressing FOXF1/MYOD1 transcription and promoting GIT1 transcription by binding the methylated CpG islands of their promoter regions16,17. Here, MECP2 is linked to gastric cancer.